Sarah Lensen, Vincent S Paramanandam, Michaela Gabes, Gesina Kann, Theresa Donhauser, Niamh F Waters, Anna D Li, Michelle Peate, Nipuni S Susanto, Lucy E Caughey, Fatema Rangoonwal, Jingbo Liu, Patrick Condron, Panagiotis Anagnostis, David F Archer, Nancy E Avis, Robin J Bell, Janet S Carpenter, Peter Chedraui, Monica Christmas, Melanie Davies, Tim Hillard, Myra S Hunter, Stamatina Iliodromiti, Nicole G Jaff, Unnop Jaisamrarn, Hadine Joffe, Sunila Khandelwal, Ludwig Kiesel, Pauline M Maki, Gita D Mishra, Rossella E Nappi, Nick Panay, Amos Pines, Helen Roberts, Serge Rozenberg, Camilo Rueda, Jan Shifren, James A Simon, Paul Simpson, Muhammad Fidel Ganis Siregar, Petra Stute, Joan Tan Garcia, Amanda J Vincent, Wendy Wolfman, Martha Hickey
OBJECTIVE: The aim of the study is to identify suitable definitions and patient-reported outcome measures (PROMs) to assess each of the six core outcomes previously identified through the COMMA (Core Outcomes in Menopause) global consensus process relating to vasomotor symptoms: frequency, severity, distress/bother/interference, impact on sleep, satisfaction with treatment, and side effects. METHODS: A systematic review was conducted to identify relevant definitions for the outcome of side-effects and PROMs with acceptable measurement properties for the remaining five core outcomes...
April 30, 2024: Menopause: the Journal of the North American Menopause Society